Literature DB >> 3403447

Determinants of endurance in well-trained cyclists.

E F Coyle1, A R Coggan, M K Hopper, T J Walters.   

Abstract

Fourteen competitive cyclists who possessed a similar maximum O2 consumption (VO2 max; range, 4.6-5.0 l/min) were compared regarding blood lactate responses, glycogen usage, and endurance during submaximal exercise. Seven subjects reached their blood lactate threshold (LT) during exercise of a relatively low intensity (group L) (i.e., 65.8 +/- 1.7% VO2 max), whereas exercise of a relatively high intensity was required to elicit LT in the other seven men (group H) (i.e., 81.5 +/- 1.8% VO2 max; P less than 0.001). Time to fatigue during exercise at 88% of VO2 max was more than twofold longer in group H compared with group L (60.8 +/- 3.1 vs. 29.1 +/- 5.0 min; P less than 0.001). Over 92% of the variance in performance was related to the % VO2 max at LT and muscle capillary density. The vastus lateralis muscle of group L was stressed more than that of group H during submaximal cycling (i.e., 79% VO2 max), as reflected by more than a twofold greater (P less than 0.001) rate of glycogen utilization and blood lactate concentration. The quality of the vastus lateralis in groups H and L was similar regarding mitochondrial enzyme activity, whereas group H possessed a greater percentage of type I muscle fibers (66.7 +/- 5.2 vs. 46.9 +/- 3.8; P less than 0.01). The differing metabolic responses to submaximal exercise observed between the two groups appeared to be specific to the leg extension phase of cycling, since the blood lactate responses of the two groups were comparable during uphill running. These data indicate that endurance can vary greatly among individuals with an equal VO2 max.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3403447     DOI: 10.1152/jappl.1988.64.6.2622

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  84 in total

1.  Effects of endurance training on the isocapnic buffering and hypocapnic hyperventilation phases in professional cyclists.

Authors:  J L Chicharro; J Hoyos; A Lucía
Journal:  Br J Sports Med       Date:  2000-12       Impact factor: 13.800

Review 2.  Physiology of wheelchair racing in athletes with spinal cord injury.

Authors:  Yagesh Bhambhani
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 3.  The scientific basis for high-intensity interval training: optimising training programmes and maximising performance in highly trained endurance athletes.

Authors:  Paul B Laursen; David G Jenkins
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 4.  Adaptations to training in endurance cyclists: implications for performance.

Authors:  J A Hawley; N K Stepto
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

5.  Dependence of the maximal lactate steady state on the motor pattern of exercise.

Authors:  R Beneke; R M Leithäuser; M Hütler
Journal:  Br J Sports Med       Date:  2001-06       Impact factor: 13.800

Review 6.  Methods to determine aerobic endurance.

Authors:  Laurent Bosquet; Luc Léger; Patrick Legros
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 7.  A framework for understanding the training process leading to elite performance.

Authors:  David J Smith
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

8.  Impact of menstrual cycle phase on the exercise status of young, sedentary women.

Authors:  Leanne M Redman; Garry C Scroop; Robert J Norman
Journal:  Eur J Appl Physiol       Date:  2003-07-26       Impact factor: 3.078

Review 9.  Dynamics of muscle microcirculatory and blood-myocyte O(2) flux during contractions.

Authors:  D C Poole; S W Copp; D M Hirai; T I Musch
Journal:  Acta Physiol (Oxf)       Date:  2011-03-01       Impact factor: 6.311

Review 10.  Physiological differences between cycling and running: lessons from triathletes.

Authors:  Gregoire P Millet; V E Vleck; D J Bentley
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.